US 7037499
Adjuvant for transcutaneous immunization
expired A61KA61K2039/53A61K2039/54
Quick answer
US patent 7037499 (Adjuvant for transcutaneous immunization) held by The United States of America as represented by the Secretary of the Army expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/55511, A61K2039/55527